TABLETS · MEDROOTS BIOPHARMA

FEBRUT-40

INR 978
Learn more
In stock

Description

FEBRUT-40

Febuxostat 40 mg Tablets

FEBRUT-40 contains Febuxostat 40 mg, a xanthine oxidase inhibitor prescribed to help lower elevated uric acid levels in adults with chronic hyperuricemia associated with gout. By reducing the production of uric acid, FEBRUT-40 helps support long-term gout management under the supervision of a qualified healthcare professional.

Composition

Each film-coated tablet contains:

Febuxostat 40 mg

Key Features

Helps lower serum uric acid levels

Supports long-term management of chronic gout

Once-daily dosing as prescribed by a physician

Manufactured with a focus on quality, safety, and consistency

Suitable for physician-prescribed therapy

Common Clinical Uses

Chronic hyperuricemia associated with gout

Long-term uric acid management in eligible adult patients

Benefits of FEBRUT-40

Effectively reduces uric acid production by inhibiting xanthine oxidase

Supports the prevention of uric acid crystal formation when used as prescribed

Trusted quality formulation from MedRoots Biopharma

Manufactured to high pharmaceutical quality standards

Why Choose MedRoots Biopharma?

MedRoots Biopharma is a trusted name in the pharmaceutical industry, committed to delivering quality healthcare products across India. The company offers a wide range of pharmaceutical formulations backed by dependable quality, competitive pricing, and excellent customer support through its PCD Pharma Franchise network.

Our Strengths

Quality-assured pharmaceutical products

Wide product portfolio

Attractive PCD Pharma Franchise opportunities

Monopoly-based business support in selected areas

Timely product availability and promotional support

Customer-focused business approach

Marketed by: MedRoots Biopharma

Note: FEBRUT-40 should be used only under the supervision of a registered medical practitioner. It is indicated for the management of chronic hyperuricemia associated with gout and is not recommended for the treatment of asymptomatic hyperuricemia. Patients should follow their physician's advice regarding dosage, monitoring, precautions, and possible side effects.